HS-10502

· Jiangsu Hansoh Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HS-10502, covering 2025-06-05 to 2025-06-24. Get the full timeline:

Most recent: Clinical Trial Update: HS-10502 Combination Treatment in Patients With Advanced Solid Tumors [Phase 1]